P1084: Persistence and efficacy of Ustekinumab in Crohn@E@s disease after antiTNF failure. May the response of the second biologic therapy be better than the first one?ECCO'24Year: 2024
Authors: Latrás Cortés, I.(1)*;Saéz Hortelano, J.C.(2);Suárez Álvarez, P.(1);García Prada, M.(1);Cano Sanz, N.(1);Ortega Valin, L.(2);Sierra Ausín, M.(1);
(1)University Hospital of León, Gastroenterology-IBD Unit, León, Spain;(2)University Hospital of León, Pharmacology, León, Spain;
P1085: Machine learning to predict the efficacy of ustekinumab for ulcerative colitis.ECCO'24Year: 2024
Authors: Morikubo, H.(1)*;Tojima, R.(2);Maeda, T.(2);Matsuoka, K.(3);Matsuura, M.(1);Miyoshi, J.(1);Tamura, S.(2);Hisamatsu, T.(1);
(1)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Mitaka, Japan;(2)Gifu University Faculty of Engineering, Department of Electrical- Electronic and Computer Engineering, Gifu, Japan;(3)Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology- Department of Internal Medicine, Chiba, Japan;
P1086: Re-administration of infliximab in patients with extremely refractory perianal Crohn’s diseaseECCO'24Year: 2024
Authors: Mousourakis, K.(1)*;Veretanos, C.(1);Arvanitis, K.(1);Georgiadi, T.(1);Nousias, G.(1);Kozompoli, D.(1);Mylonas, I.(1);Paparizou, A.(1);Karaouzas, L.(1);Kalogiros, G.(1);Patsi, M.(1);Provi, D.(1);Christidou, A.(1);Mela, M.(1);Archavlis, E.(1);Papastergiou, V.(1);Varytimiadis, K.(1);Katopodi, K.(1);Chatzievangelinou, C.(1);Viazis, N.(1);
(1)Evangelismos Hospital, Gastroenterology Department, Athens, Greece;
P1087: A retrospective study on the GLIM criteria for assessing malnutrition in patients with Crohn@E@s Disease and its correlation with clinical outcomes.ECCO'24Year: 2024
Authors: Song, X.(1)*;Zhou, X.(2);Yang, J.(2);Guo, H.(1);
(1)Chongqing General Hospital, Gastroenterology, Chongqing, China;(2)The Third Affiliated Hospital of Chongqing Medical University, Research Center for Metabolic and Cardiovascular Diseases-Department of Clinical Nutrition., Chongqing, China;
P1088: Real-world data on the treatment with Upadacitinib in a biological-experienced Crohn@E@s disease cohortECCO'24Year: 2024
Authors: Kubesch, A.(1)*;Lande, R.(1);Farrag, K.(1);Jungheim, F.(1);Dienethal, A.(1);Sprinzl, K.(1);Zeuzem, S.(1);Blumenstein, I.(1);
(1)Goethe University Frankfurt- University Hospital- Medical Clinic 1, Department of Gastroenterology and Hepatology, Frankfurt, Germany;
P1089: Disease characteristics at time of diagnosis of adult onset inflammatory bowel disease and the risk of venous thromboembolism in the modern era – A Swedish nationwide cohort study 2007-2021ECCO'24Year: 2024
Authors: Bröms, G.(1)*;Forss, A.(1);Eriksson, J.(1);Linder, M.(1);Eriksson, C.(2);Askling, J.(1);Halfvarson, J.(2);Ludvigsson, J.F.(3);Olen, O.(1);
(1)Karolinska institutet, Medicine Solna, Stockholm, Sweden;(2)Örebro University, Gastroenterology, Örebro, Sweden;(3)Karolinska institutet, Medical Epidemiology and Biostatistics, Stockholm, Sweden;
P108: Response to vedolizumab in ulcerative colitis is associated with reduced neutrophil extracellular traps formation and IL-1β production: insights from NEUTROVED study.ECCO'24Year: 2024
Authors: Gavriilidis, E.(1);Divolis, G.(2);Kafalis, N.(3)*;Kogias, D.(1);Natsi, A.M.(4);Antoniadou, C.(1);Papadimitriou, E.(1);Tsironidou, V.(4);Giatromanolaki, A.(5);Ritis, K.(1);Kouklakis, G.(3);Skendros, P.(1);
(1)Democritus University of Thrace, First Department of Internal Medicine- University Hospital of Alexandroupolis, Alexandroupolis, Greece;(2)Biomedical Research Foundation Academy of Athens, Center for Clinical- Experimental Surgery and Translational Research, Athens, Greece;(3)Democritus University of Thrace, Gastroenterology-Hepatology Unit- University Hospital of Alexandroupolis, Alexandroupolis, Greece;(4)Democritus University of Thrace, Laboratory of Molecular Hematology, Alexandroupolis, Greece;(5)Democritus University of Thrace, Department of Pathology- University Hospital of Alexandroupolis, Alexandroupolis, Greece;
P1090: Exposure to an inflammatory prenatal environment and the risk of Inflammatory Bowel Disease in the offspring: a population-based cohort studyECCO'24Year: 2024
Authors: Bonfils, L.(1)*;Poulsen, G.(1);Agrawal, M.(1,2);Julsgaard, M.(1,3);Torres, J.(2,4,5);Jess, T.(1,6);Allin, K.(1,6);
(1)Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT, Department of Clinical Medicine- Aalborg University, Copenhagen, Denmark;(2)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York City, United States;(3)Aarhus University Hospital, Department of Hepatology and Gastroenterology- Aarhus University Hospital, Aarhus, Denmark;(4)Hospital da Luz, Division of Gastroenterology, Lisboa, Portugal;(5)Hospital Beatriz Ângelo, Division of Gastroenterology, Loures, Portugal;(6)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
P1091: Cross-domain dynamics of the fungal-bacterial microbiome in patients with ulcerative colitisECCO'24Year: 2024
Authors: Jangi, S.(1)*;Hsia, K.(2);zhao, N.(3);michaud, D.(3);
(1)Tufts Medical Center, Gastroenterology, Cambridge, United States;(2)Tufts Medical Center, Medicine, Boston, United States;(3)Tufts Medical Center, Public Health, Boston, United States;
P1093: Early life exposure to agriculture and biodiversity influences Crohn’s disease risk in a population-based cohort studyECCO'24Year: 2024
Authors: Agrawal, M.(1,2)*;Vinkel Hansen, A.(2);Colombel, J.F.(1);Jess, T.(2,3);Allin, K.(2,3);
(1)Icahn School of Medicine at Mount Sinai, The Dr. Henry D. Janowitz Division of Gastroenterology, New York, United States;(2)Aalborg University, Center for Molecular Prediction of Inflammatory Bowel Disease PREDICT- Department of Clinical Medicine, Copenhagen, Denmark;(3)Aalborg University Hospital, Department of Gastroenterology & Hepatology, Aalborg, Denmark;
P1094: Rectal cancer in patients with inflammatory bowel disease - a nationwide cohort studyECCO'24Year: 2024
Authors: Lundqvist, E.(1)*;Westerberg, K.(2);Dietrich, C.(3);Martling, A.(4);Myrelid, P.(5);Nordenvall, C.(4);
(1)PhD-student- MD, Department of Biomedical and Clinical Sciences- Linköping University, Linköping, Sweden;(2)Karolinska Institute, Department of Molecular Medicine and Surgery-, Stockholm, Sweden;(3)Karolinska Institute, Division of Clinical Epidemiology- Department of Medicine, Stockholm, Sweden;(4)Karolinska Institute, Department of Molecular Medicine and Surgery, Stockholm, Sweden;(5)Linköping University, Department of Biomedical and Clinical Sciences, Stockholm, Sweden;
P1095: Impact of inflammatory bowel disease on the risk of acute coronary syndrome: A Swedish Nationwide cohort study 2003-2021ECCO'24Year: 2024
Authors: Eriksson, C.(1)*;Sun, J.(2);Bryder, M.(1);Bröms, G.(1);Everhov, Å.H.(1);Forss, A.(1);Jernberg, T.(3);Ludvigsson, J.F.(2);Olén, O.(1);
(1)Clinical Epidemiology Division, Department of Medicine Solna- Karolinska Institutet, Stockholm, Sweden;(2)Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;(3)Department of Clinical Sciences Danderyd University Hospital, Karolinska Institutet, Stockholm, Sweden;
P1096: Increased incidence of IBD over 22 years in an Argentine cohortECCO'24Year: 2024
Authors: Sanchez, M.B.(1)*;Gonzalez Sueyro, R.(1);Sobrero, M.J.(1);Etchevers, M.J.(1);Martinez Elhelou, S.(1);Manduca, P.A.(1);Mulinaris, A.B.(1);Musso Enz, V.(2);Ligo, M.C.(2);Brave, C.(2);de Paula, J.A.(1);Marcolongo, M.M.(1);
(1)Hospital Italiano de Buenos Aires, Gastroenterology, Buenos Aires, Argentina;(2)Hospital Italiano de Buenos Aires, University Institute, Buenos Aires, Argentina;
P1097: The effect of lockdowns during the COVID-19 pandemic on the epidemiology of inflammatory bowel diseases: a comparison of two nationwide cohortsECCO'24Year: 2024
Authors: Atia, O.(1)*;Bryder, N.(2);Mendelovici, A.(1);Ledderman, N.(3);Ben-Tov, A.(4);Osooli, M.(2);Forss, A.(2);Loewenberg Weisband, Y.(5);Matz, E.(6);Dotan, I.(7);Turner, D.(1);Olén, O.(8);
(1)Shaare Zedek Medical Center- The Hebrew University of Jerusalem- Israel., Juliet Keidan Institute of Pediatric Gastroenterology Hepatology and Nutrition, Jerusalem, Israel;(2)Clinical Epidemiology Division- Karolinska Institute, Department of Medicine Solna, Stockholm, Sweden;(3)Meuhedet Health Services, Meuhedet Health Services, Tel-Aviv, Israel;(4)Maccabi Healthcare Services- the Sackler Faculty of Medicine- Tel Aviv University, Kahn-Sagol-Maccabi Research and Innovation Center, Tel Aviv, Israel;(5)Clalit Health Services, Clalit Research Institute, Tel-Aviv, Israel;(6)Leumit Health Services, Leumit Health Services, Tel-Aviv, Israel;(7)Rabin Medical Center and the Faculty of Medicine- Tel Aviv University, Division of Gastroenterology, Petah Tikva, Israel;(8)Clinical Epidemiology Division- Karolinska Institute and 8. Sachs’ Children and Youth Hospital- Stockholm South General Hospital, Department of Medicine Solna, Stockholm, Sweden;
P109: Organic Cation Transporter (OCTN)-1 variants shape innate immunity and predict individual response to vedolizumab In ulcerative colitis patientsECCO'24Year: 2024
Authors: Capobianco, I.(1,2)*;Puca, P.(1,2);Masi, L.(1,2);Petito, V.(1,2);Pafundi, P.C.(3);De Felice, M.(2);Fidaleo, M.(4);Di Vincenzo, F.(1,2);Del Chierico, F.(5);Delogu, G.(6);Palucci, I.(6);Laterza, L.(1);Pizzoferrato, M.(1);Schiavoni, E.(1);Napolitano, D.(1);Turchini, L.(1);Amatucci, V.(1);Strazzeri, M.(1);Pugliese, D.(1);Putignani, L.(7);Armuzzi, A.(8);Lopetuso, L.R.(1);Gasbarrini, A.(1);Pani, G.(2);Scaldaferri, F.(1);
(1)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, IBD Unit- Digestive Diseases Center CEMAD, Rome, Italy;(2)Università Cattolica del Sacro Cuore, Department of Translational Medicine and Surgery, Rome, Italy;(3)Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Epidemiology and Biostatistics Research Core Facility- Gemelli Generator, Rome, Italy;(4)University La Sapienza, Department of Biology and Biotechnology “Charles Darwin”, Rome, Italy;(5)Bambino Gesù Pediatric Hospital IRCCS, Unit of Human Microbiome – “San Paolo” Research Center, Rome, Italy;(6)Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Department of Microbiology and Clinical Virology, Rome, Italy;(7)Bambino Gesù Children@E@s Hospital- IRCCS, Department of Diagnostic and Laboratory Medicine- Unit of Microbiology and Diagnostic Immunology- Unit of Microbiomics and Multimodal Laboratory Medicine Research Area- Unit of Human Microbiome, Rome, Italy;(8)IRCCS Humanitas Research Hospital, IBD Center, Rozzano- Milan, Italy;
P1100: A multivariate time-dependent proportional hazard model to predict development of intestinal failure from Crohn’s DiseaseECCO'24Year: 2024
Authors: Wu, T.H.(1)*;Brandt, C.F.(1);Scheike, T.(2);Burisch, J.(3);Jeppesen, P.B.(1);
(1)Rigshospitalet, Department of Intestinal Failure and Liver Diseases, Copenhagen, Denmark;(2)University of Copenhagen, Department of Public Health- Biostatistics Section, Copenhagen, Denmark;(3)Hvidore Hospital, Department of Medical Gastroenterology, Copenhagen, Denmark;
P1101: Patient-reported physical activity of IBD patients is of concern when weighed with the international physical activity questionnaire regardless of disease activity and IBD phenotype: barriers and facilitators emerged from the extended @D@BE-FIT-IBD@D@ cross-sectional study.ECCO'24Year: 2024
Authors: Gravina, A.G.(1);Pellegrino, R.(1)*;Palladino, G.(1);Imperio, G.(1);D@E@Onofrio, R.(1);Arboretto, G.(1);Romeo, M.(1);Ciamarra, P.(1);Dallio, M.(1);Federico, A.(1);
(1)University of Campania Luigi Vanvitelli, Department of Precision Medicine, Naples, Italy;
P1102: Adherence to a Mediterranean dietary pattern in patients with Crohn@E@s disease in remission is associated with lower fecal calprotectin levelsECCO'24Year: 2024
Authors: Mor-Sasson, L.(1)*;Sarbagili-Shabat, C.(2,3);Sherf-Dagan, S.(1,4);Aviv Cohen, N.(2,3);Ron, Y.(2,3);Hirsch, A.(2,3);Thurm, T.(2,3);Maharshak, N.(2,3);Fliss-Isakov, N.(2,3);
(1)Ariel University, Department of Nutrition Sciences, Ariel, Israel;(2)Tel Aviv University, Faculty of Medicine, Tel Aviv, Israel;(3)Tel Aviv Medical Center, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(4)Assuta Medical Center, Department of Nutrition, Tel Aviv, Israel;
P1103: Incidence of Crohn@E@s disease in patients with perianal fistula surgeryECCO'24Year: 2024
Authors: Kim, S.(1)*;Kim, S.P.(2);Park, Y.(3);Kim, S.H.(4);Kim, Y.E.(5);Choi, H.(5);Oh, S.(5);Yu, C.S.(6);Yoon, H.J.(7);Kim, K.(5);
(1)Chonnam National University Children@E@s Hospital, Department of Pediatrics, Gwangju, Korea- Republic Of;(2)Seoul National University College of Medicine, Interdisciplinary Program of Medical Informatics, Seoul, Korea- Republic Of;(3)Seoul National University College of Medicine, Department of Biomedical Engineering, Seoul, Korea- Republic Of;(4)Seoul National University Hospital, Biomedical Research Institute, Seoul, Korea- Republic Of;(5)Asan Medical Center Children’s Hospital- University of Ulsan College of Medicine, Department of Pediatrics, Seoul, Korea- Republic Of;(6)Asan Medical Center- University of Ulsan College of Medicine, Department of Colon and Rectal Surgery, Seoul, Korea- Republic Of;(7)Seoul National University College of Medicine, Medical Bigdata Research Center, Seoul, Korea- Republic Of;
P1104: Shifting Surgical Landscape in Crohn@E@s Colitis: Laparoscopic Supremacy and Robotic UpsurgeECCO'24Year: 2024
Authors: Violante, T.(1)*;Ferrari, D.(2);Novelli, M.(3);Larson, D.(2);
(1)Mayo Clinic, Division of Colon and Rectal Surgery, Rochester, United States;(2)Mayo Clinic Rochester, Division of Colon and Rectal Surgery, Rochester, United States;(3)Alma Mater Studiorum Bologna University, Department of Statistics, Bologna, Italy;
